According to Future Market Insights’ newly released Extracorporeal CO2 Removal Devices Market industry analysis report, global sales of the Extracorporeal CO2 Removal Devices Market in 2021 will be US$ 91.6 Million. The market is expected to reach a valuation of US$ 170.9 Million by 2032, with a CAGR of 5.8% between 2022 and 2032. Extracorporeal CO2 Machines …
Category Archives: Healthcare Trends
Lyophilized Injectable Market is currently valued at US$ 3043.55 Million in 2023 | FMI
The global Lyophilized Injectable Market is expected to grow at a steady 5.8% over the next few years. In 2023, the lyophilized injectable market is expected to be worth $3043.55 million. Demand for lyophilized injectables is expected to reach a peak of US$ 5348.56 Mn by 2033. Because of their stability at room temperature, lyophilized medications are …
Wheelchairs Market to reach a valuation of ~US$ 7.9 Billion by the year 2032, at a CAGR of 3.2% from 2022 to 2032
As per Future Market Insights’ latest industry analysis, the valuation for the global wheelchairs market was around US$ 5.5 Bn in 2021, and is projected to exhibit growth at a CAGR of close to 3.2% over the forecast period. Market Outlook: Data Points Market Insights Market Value 2021 US$ 5.5 Billion Market Value 2022 US$ 5.7 Billion Market Value 2032 US$ …
Kidney Transplant Market is anticipated to rise at a CAGR of 4.2% from 2023 to 2033 | FMI Study
As per Future Market Insights’ latest industry analysis, the valuation for the global Kidney Transplant Market was around US$ 5.8 Billion in 2022 and is projected to exhibit a CAGR of 4.2% over the forecast period, with an estimated valuation of US$ 9.1 Billion in 2033. The global burden of chronic kidney diseases is increasing at a higher rate. One of just a …
Cell Therapy Manufacturing Market size is anticipated to reach a valuation of ~US$ 13.9 Billion by 2032, at a CAGR 14.2% from 2022 to 2032
As per Future Market Insights’ latest industry analysis, the valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and is projected to exhibit a CAGR of close to 14.2% over the forecast period. The market is expected to reach US$ 13.9 Bn in 2032. Cell therapies are utilized widely to treat viral infections, cancer, hemoglobinopathies, and hereditary immunological disorders. Introduction …
Immunoassay Market demand analysis is expected to be worth USD 45.78 billion by 2032, at a CAGR 5% from 2022 to 2032
The immunoassay market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022 The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factors …
HER2 Positive Gastric Cancer Market is expected to be valued at US$ 1779.8 million by 2033, at a CAGR of 3.5% | FMI Report
The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$1779.8 million by 2033. “Increased disease burden and pipeline candidate approval are likely to drive the growth of the HER2 positive …
Intestinal Fistula Treatment Market is estimated to total US$ 46.82 billion, at a CAGR of 5.8% | FMI Report
The global Intestinal Fistula Treatment Market is expected to be valued at US$ 26.64 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for intestinal fistula treatment is projected to grow at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 46.82 Billion by 2033. Factors such as …
Prinzmetal Angina Therapeutics Market will grow to be one of the most lucrative in North America | FMI Analyst
The global Prinzmetal Angina Therapeutics Market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of alcohol …
Acrocallosal Syndrome Therapeutics Market is expected to reach a valuation of US$ 412.4 Million, at a CAGR of 10.8% | FMI Analyst
The global Acrocallosal Syndrome Therapeutics Market is now valued at US$ 147.9 million in 2023, with a CAGR of 10.8% expected. Because to technological advancements in healthcare, the market is expected to reach US$ 412.4 million by 2033. An increase in the number of patients seeking treatment, as well as rising demand for improved healthcare …